Review examines whether GLP-1 drugs can achieve true diabetes remission — sustained normalization of blood sugar without medication — and identifies who is most likely to achieve it.
Key findingReview examines whether GLP-1 drugs can achieve true diabetes remission — sustained normalization of
What the researchers found
Review examines whether GLP-1 drugs can achieve true diabetes remission — sustained normalization of blood sugar without medication — and identifies who is most likely to achieve it.
Why it matters
Relevant to peptide therapeutics.
The numbers in context
India has alarming and rising diabetes prevalence. Remission defined as sustained normal blood sugar without medication.
How the study worked
In publication.
Who was studied
Adults with type 2 diabetes, with focus on the Indian population
What this study cannot tell us
In publication.
How to read the evidence
Based on design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide evidence.
Questions still open
- Long-term implications?
- Evidence comparison?
- Next steps?
Common questions
What does this mean?
How reliable?
Read the original research
Achieving Diabetes Remission: Current Guidelines and Emerging Pharmacotherapies in India.
The Journal of the Association of Physicians of India, 73(10), 83-86
Citation
Arpan; Singh, Navrajbir; Bali, Kusum; Singh, Tarundeep. (2025). Achieving Diabetes Remission: Current Guidelines and Emerging Pharmacotherapies in India.. The Journal of the Association of Physicians of India, 73(10), 83-86. https://doi.org/10.59556/japi.73.1184